Search clinical trials for: multiple myeloma

Total 12953 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs)

Peritonitis

Germany
Orion Corporation, Orion Pharma

Completed

Safety and Tolerability Study With Multiple Ascending Doses of ORM-12741

Healthy

France
Xenon Pharmaceuticals Inc.

Completed

Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers

Healthy Human Volunteers

Canada
Biogen

Completed

A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)

Relapsing Forms of Multiple Sclerosis

United States
Onze Lieve Vrouwe Gasthuis

Completed

Nadroparin Anticoagulation for Continuous Venovenous Hemofiltration

Acute Renal Failure | Multiple Organ Failure | Kidney

Netherlands
AstraZeneca

Completed

Study to Assess the Safety, Tolerability and Pharmacokinetics After Multiple Doses of AZD2066 in Japanese Subjects

Healthy

Japan
Ziv Hospital

Unknown

Comparison of On-line and Off-line Measurements of Exhaled Nitric Oxide (NO)

Asthma | Primary Ciliary Dyskinesia

Israel
Ziv Hospital

Unknown

Screening for Primary Ciliary Dyskinesia Using Nasal Nitric Oxide

Primary Ciliary Dyskinesia

Israel
Università Vita-Salute San Raffaele

Terminated

Hemodilution and Outcome in Cardiac Surgery

Intraoperative Complications | Kidney Failure

Italy
BioMS Technology Corp.

Terminated

Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis (MAESTRO-03)

Multiple Sclerosis, Secondary Progressive
Pfizer

Completed

A Phase 1 Multiple-Dose Escalation and Single Dose (Tablet) Study of PF-04171327 in Healthy Volunteers

Healthy Volunteers

Belgium
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Determine the Impact of Multiple Doses of Rifampin on Single-dose Pharmacokinetics of HCV-796

Healthy
Pfizer

Completed

A Multiple Dose Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04457845 in Healthy Volunteers

Chronic Pain | Acute Pain

Singapore
University of Sao Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Unknown

Oral Language in Children With Down Syndrome

Down Syndrome

Brazil
Wyeth is now a wholly owned subsidiary of Pfizer
Solvay Pharmaceuticals

Terminated

Study Evaluating Multiple Ascending Dose in Schizophrenia Patients

Healthy
AstraZeneca

Completed

Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2) (CYP)

Healthy

United Kingdom
Humanigen, Inc.

Completed

Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosa

Ventilator Associated Pneumonia | Pseudomonas Aeruginosa

France
Pfizer

Terminated

Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531

Alzheimer Disease

France
AstraZeneca

Completed

Study to Investigate Safety, Tolerability and PK Following Single and Multiple Ascending Doses of AZD7295 in Japanese

Healthy Subjects

Japan
Stony Brook University

Withdrawn

Phase II High-Dose Cyclophosphamide for Multiple Sclerosis

Multiple Sclerosis

United States
University Hospital Inselspital, Berne
PharmaPart; Laboratory: Viollier AG Spalenring 145 / 147 Postfach 4002 Basel

Completed

Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b (SWABIMS)

Multiple Sclerosis

Switzerland
TransMolecular

Unknown

A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma

Astrocytoma | Glioblastoma Multiforme | Malignant Glioma | GBM | Oligodendroglioma

United States
AstraZeneca

Completed

AZD2624 Multiple Ascending Dose Study in Japan (JMAD)

Healthy | Safety

Japan
Pfizer

Completed

Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis

Arthritis, Rheumatoid

United States, Czech Republic, Bulgaria, Poland, Slovakia, Spain, Mexico, Argentina
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects

Healthy

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Determine the Impact of Multiple Doses of Ketoconazole on Single-Dose Pharmacokinetics of HCV-796

Healthy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI

Abdominal Abscess

Taiwan
AstraZeneca

Completed

Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236

Healthy Volunteer

Japan
Pfizer

Completed

A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis

Colitis, Ulcerative

Spain, Belgium, Germany, Czech Republic, Norway, Denmark, Slovakia
AstraZeneca

Completed

AZD8529 Multiple Ascending Dose Study in Healthy Subjects

Healthy Volunteer
Boston Scientific Corporation

Completed

EASYTRAK 3 Downsize Lead

Heart Failure

United States
University of North Carolina, Chapel Hill

Completed

EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis

Multiple Sclerosis

United States
Biogen

Completed

Open-Label Natalizumab Safety Extension Study

Multiple Sclerosis

United States
Biogen
Elan Pharmaceuticals

Completed

Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

United States, Germany, Austria, Belgium, France, Israel, Italy
Biogen
Elan Pharmaceuticals

Completed

Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
Chang Gung Memorial Hospital
National Science Council, Taiwan

Completed

Diagnosis of Lung Lesions by Endobronchial Ultrasound With an Alternative Guide Sheath

Pulmonary Neoplasms | Solitary Pulmonary Nodules

Taiwan
Biogen

Completed

GER-009-06-AVX Early Therapy in Multiple Sclerosis (FIT)

Relapsing-Remitting Multiple Sclerosis
Pfizer

Completed

A Study to Evaluate Safety, Tolerability, Plasma Drug Levels, and Cognitive Response Following Multiple Doses of a Drug in Healthy Elderly Participants.

Healthy | Elderly

United States
Seoul National Hospital

Unknown

Association of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in Schizophrenia

Schizophrenia | Metabolic Syndrome | Genetic Polymorphism

Korea, Republic of
King's College London
National Multiple Sclerosis Society

Completed

Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS)

Multiple Sclerosis

United Kingdom
Cantonal Hospital of St. Gallen

Unknown

The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis

Switzerland
Biogen

Completed

Immunogenicity and Safety Study of Serum-Free Avonex

Multiple Sclerosis
Abbott

Completed

Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood

Dyslipidemia | Coronary Heart Disease | Mixed Dyslipidemia

United States
Biogen

Completed

Open-Label Safety Extension Study of Avonex

Multiple Sclerosis
Phenomix

Unknown

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States, Argentina, Canada, India, Mexico
Biogen

Completed

Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe

Multiple Sclerosis
Washington Neuropsychology Research Group
Genzyme, a Sanofi Company

Unknown

Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)

Relapsing Remitting Multiple Sclerosis

United States
Biogen

Completed

Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers

Multiple Sclerosis
Sanofi

Completed

Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)

Diabetes Mellitus

United States

3

Subscribe